/UPC

UPC Stock - Universe Pharmaceuticals Inc.

Q: What is the analyst price target for UPC?

Analyst price target information is not currently available for UPC.

Q: What is UPC's market cap?

Market capitalization information is not currently available for UPC.

Healthcare|Drug Manufacturers - Specialty & Generic|NASDAQ

$3.73+2.40%

+$0.09 (+2.40%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $4.10

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for UPC

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.52

52W High$28.00

52W Low$2.51

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$23.02M	$32.31M	$40.14M	$47.98M	$30.70M
Gross Profit	$6.07M	$10.32M	$21.89M	$25.33M	$14.09M
Gross Margin	26.4%	31.9%	54.5%	52.8%	45.9%
Operating Income	$-8,019,840	$-3,526,774	$-7,019,445	$13.59M	$10.25M
Net Income	$-8,727,298	$-6,163,061	$-8,736,566	$11.32M	$7.56M
Net Margin	-37.9%	-19.1%	-21.8%	23.6%	24.6%
EPS	$-1436.12	$-1040.53	$-1475.02	$2147.18	$1295.70

Company Overview

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Visit Website

Earnings History & Surprises

UPC

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$N/A

EPS Surprise History

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2024	Apr 30, 2024	—	—	—	—
Q1 2024	Feb 9, 2024	—	—	—	—

Frequently Asked Questions about UPC

What is UPC's current stock price?

Universe Pharmaceuticals Inc. (UPC) is currently trading at $3.73 per share. The stock has moved +2.40% today.

What is the analyst price target for UPC?

No analyst price targets are currently available for this stock.

What sector is Universe Pharmaceuticals Inc. in?

Universe Pharmaceuticals Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the NASDAQ exchange.

What is UPC's market cap?

Universe Pharmaceuticals Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does UPC pay dividends?

No, Universe Pharmaceuticals Inc. does not currently pay a dividend to shareholders.